CA2660289A1 - Polymer particles including covalently bonded chemical species - Google Patents

Polymer particles including covalently bonded chemical species Download PDF

Info

Publication number
CA2660289A1
CA2660289A1 CA002660289A CA2660289A CA2660289A1 CA 2660289 A1 CA2660289 A1 CA 2660289A1 CA 002660289 A CA002660289 A CA 002660289A CA 2660289 A CA2660289 A CA 2660289A CA 2660289 A1 CA2660289 A1 CA 2660289A1
Authority
CA
Canada
Prior art keywords
polymer
particle
chemical species
bonded
monomer units
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002660289A
Other languages
English (en)
French (fr)
Inventor
Robert Richard
Janel L. Lanphere
Goldi Kaul
Sharon Mi Lyn Tan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Ltd Barbados
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2660289A1 publication Critical patent/CA2660289A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002660289A 2006-08-16 2007-06-20 Polymer particles including covalently bonded chemical species Abandoned CA2660289A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82254506P 2006-08-16 2006-08-16
US60/822,545 2006-08-16
PCT/US2007/071636 WO2008021619A2 (en) 2006-08-16 2007-06-20 Polymer particles including covalently bonded chemical species

Publications (1)

Publication Number Publication Date
CA2660289A1 true CA2660289A1 (en) 2008-02-21

Family

ID=38805573

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002660289A Abandoned CA2660289A1 (en) 2006-08-16 2007-06-20 Polymer particles including covalently bonded chemical species

Country Status (5)

Country Link
US (1) US20080045654A1 (OSRAM)
EP (1) EP2056879A2 (OSRAM)
JP (1) JP2010500997A (OSRAM)
CA (1) CA2660289A1 (OSRAM)
WO (1) WO2008021619A2 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090169471A1 (en) * 2007-12-28 2009-07-02 Boston Scientific Scimed, Inc. Particles for injection and processes for forming the same
WO2009086076A2 (en) * 2007-12-28 2009-07-09 Boston Scientific Scimed, Inc. Particles for injection and processes for forming the same
EP2341953B1 (en) 2008-09-04 2018-11-21 The General Hospital Corporation Hydrogels for vocal cord and soft tissue augmentation and repair
WO2011109730A2 (en) 2010-03-04 2011-09-09 The General Hospital Corporation Methods and systems of matching voice deficits with a tunable mucosal implant to restore and enhance individualized human sound and voice production
US9790335B2 (en) 2010-05-13 2017-10-17 Pennsylvania College Of Technology Bio-derived polymers having improved processability and method for the production thereof
US10784026B2 (en) * 2019-01-20 2020-09-22 Littelfuse, Inc. PPTC composition and device having low switch temperature and sharp crystallization behaviour

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3101991A (en) * 1960-01-21 1963-08-27 Kurashiki Rayon Co Production of polyvinyl formal shaped articles
US3125556A (en) * 1961-04-27 1964-03-17 Process of making hydroxyalkylated
FR86718E (fr) * 1963-11-25 1966-04-01 Procédé d'insolubilisation des alcools polyvinyliques et produits obtenus
SE361320B (OSRAM) * 1972-03-14 1973-10-29 Exploaterings Ab Tbf
US4182805A (en) * 1975-10-30 1980-01-08 Polaroid Corporation Decyanation
US4897255A (en) * 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
SU1705304A1 (ru) * 1987-02-25 1992-01-15 Предприятие П/Я В-2913 Сшитый полимер на основе поливинилового спирта и способ его получени
US5118758A (en) * 1991-05-10 1992-06-02 Dow Corning Corporation Coprecipitated silicate-carbinol particles
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5350801A (en) * 1993-07-07 1994-09-27 Air Products And Chemicals, Inc. Solid state process for modification of polyvinyl alcohol using Michael-type addition
JPH08113611A (ja) * 1994-10-14 1996-05-07 Nippon Oil & Fats Co Ltd アクリダン基含有ポリビニルアルコールおよび化学発光方法
JPH09291110A (ja) * 1996-04-24 1997-11-11 Dai Ichi Kogyo Seiyaku Co Ltd 変性ポリビニルアルコール及び変性ポリビニルアルコール粉末品の製造方法
US6368658B1 (en) * 1999-04-19 2002-04-09 Scimed Life Systems, Inc. Coating medical devices using air suspension
US20020022144A1 (en) * 2000-05-19 2002-02-21 Hu Yang Enhanced oxygen barrier performance from modification of ethylene vinyl alcohol copolymers (EVOH)
DE60230674D1 (de) * 2001-12-21 2009-02-12 Ciba Holding Inc Polyvinylalkohol-poly(n-vinylformamid) kopolymere
US7131997B2 (en) * 2002-03-29 2006-11-07 Scimed Life Systems, Inc. Tissue treatment
US7053134B2 (en) * 2002-04-04 2006-05-30 Scimed Life Systems, Inc. Forming a chemically cross-linked particle of a desired shape and diameter
US7838699B2 (en) * 2002-05-08 2010-11-23 Biosphere Medical Embolization using degradable crosslinked hydrogels
JP2005535752A (ja) * 2002-08-09 2005-11-24 ボストン サイエンティフィック リミテッド 塞栓術
US7449236B2 (en) * 2002-08-09 2008-11-11 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US20040076582A1 (en) * 2002-08-30 2004-04-22 Dimatteo Kristian Agent delivery particle
US8012454B2 (en) * 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7588825B2 (en) * 2002-10-23 2009-09-15 Boston Scientific Scimed, Inc. Embolic compositions
US7901770B2 (en) * 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
US20060045900A1 (en) * 2004-08-27 2006-03-02 Robert Richard Embolization
US8425550B2 (en) * 2004-12-01 2013-04-23 Boston Scientific Scimed, Inc. Embolic coils
US7727555B2 (en) * 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US8101197B2 (en) * 2005-12-19 2012-01-24 Stryker Corporation Forming coils
US20070142560A1 (en) * 2005-12-21 2007-06-21 Young-Ho Song Block copolymer particles
US7501179B2 (en) * 2005-12-21 2009-03-10 Boston Scientific Scimed, Inc. Block copolymer particles
US7947368B2 (en) * 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
EP1873671B2 (en) * 2006-06-29 2018-08-22 STMicroelectronics International N.V. A method for protecting IC Cards against power analysis attacks
US9481752B2 (en) * 2006-07-27 2016-11-01 Boston Scientific Scimed, Inc. Polymeric particles comprising vinyl formal, vinyl alcohol and vinyl acetate monomer units

Also Published As

Publication number Publication date
WO2008021619A3 (en) 2009-03-12
EP2056879A2 (en) 2009-05-13
US20080045654A1 (en) 2008-02-21
JP2010500997A (ja) 2010-01-14
WO2008021619A2 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
CA2660289A1 (en) Polymer particles including covalently bonded chemical species
CA2686414A1 (en) Compositions and methods for treating disorders associated with salt or fluid retention
Arias et al. Magnetic targeting of smooth muscle cells in vitro using a magnetic bacterial cellulose to improve cell retention in tissue-engineering vascular grafts
Aurelio et al. Contrast-induced nephropathy in percutaneous coronary interventions: pathogenesis, risk factors, outcome, prevention and treatment
Xie et al. Iron oxide nanoparticles as autophagy intervention agents suppress hepatoma growth by enhancing tumoricidal autophagy
Braga et al. Supercritical solvent impregnation of ophthalmic drugs on chitosan derivatives
EP0938343A2 (en) Tumor delivery vehicles and method to enhance treatment of cystic tumors
KR20160084846A (ko) 중합체 입자
Parisi et al. Controlled release of sunitinib in targeted cancer therapy: Smart magnetically responsive hydrogels as restricted access materials
Hagan et al. Predicting pharmacokinetic behaviour of drug release from drug-eluting embolization beads using in vitro elution methods
JP2002543940A (ja) 放射性ステントの形成方法
EP2854869B1 (en) Biomaterials suitable for use as drug eluting, magnetic resonance imaging detectable implants for vascular occlusion
US11497836B2 (en) Systems and methods for forming materials in situ within a medical device
CA3237741A1 (en) Vascular embolic agent, method for preparing same and use thereof
US6096303A (en) Method to enhance treatment of cystic tumors
US20180369446A1 (en) Curable silicone (pre-) polymer composition comprising a contrast agent
Sim et al. Synergistic photodynamic therapeutic effect of indole-3-acetic acid using a pH sensitive nano-carrier based on poly (aspartic acid-graft-imidazole)-poly (ethylene glycol)
AU2019212513B2 (en) Apparatus and method of using in situ solidifying complex coacervates for vascular occlusion
WO2024206400A1 (en) Liquid embolic materials
US20240325592A1 (en) Liquid embolic materials
JP2008194362A (ja) 抗血栓コーティング剤及び医療用具
WO2019084548A1 (en) COMPLEX LIQUID IN SITU SOLIDIFICATION COASTALITIES FOR LOCAL ADMINISTRATION OF ANTI-ANGIOGENIC AGENTS OR CHEMOTHERAPEUTIC AGENTS
Lewis et al. Biomedical applications of hydrogels: poly (vinyl alcohol)-based hydrogels for embolotherapy and drug delivery
NL2015809B1 (en) Composition for use in the treatment or prevention of endoleak.
York-Durán Design, characterisation and in vitro evaluation of a multicompartment carrier in the submicron range

Legal Events

Date Code Title Description
FZDE Discontinued